drugset
drugset / Trial / NCT02679911

Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer

NCT02679911 ↗

Phase 4 Completed 20 enrolled Galderma R&D
RandomizedParallel-groupSingle-blindTreatment

Summary

The main objective of this study is to compare subject's compliance and satisfaction for two modes of treatment of toenails infection (Onychomycosis) with Loceryl Nail Lacquer (Loceryl NL) and Ciclopirox Nail Lacquer (Ciclopirox NL).

Timeline

Start
2015-09
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Amorolfine Small molecule 5 % Topical
Comparator Ciclopirox Unknown 8 % Topical

Indications

dermatophytosis